Gadolinium-binding helix–turn–helix peptides: DNA-dependent MRI contrast agents†
Abstract
A de novo designed gadolinium metallopeptide was found to be a very efficient relaxation agent, with 100% increase in relaxivity upon binding to DNA.
Please wait while we load your content...
Supplementary files
Article information
- Article type
- Communication
- Submitted
- 09 Jul 2003
- Accepted
- 12 Aug 2003
- First published
- 12 Sep 2003
Chem. Commun., 2003, 2574-2575
Permissions
Gadolinium-binding helix–turn–helix peptides : DNA-dependent MRI contrast agents
P. Caravan, J. M. Greenwood, J. T. Welch and S. J. Franklin, Chem. Commun., 2003, 2574 DOI: 10.1039/B307817E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
